M
MESO
Mesoblast
14.81
-0.99-6.27%After Hours: 14.81 0.00 0.00%16:10 04/02 EDT
OPEN/PREV CLOSE14.09/13.69
TODAY RANGE13.79-14.41
VOL343.99K
MARKET CAP1.79B
52 WEEK RANGE9.61-21.50
AVG VOL (3M)265.06K
% TURNOVER0.27%
TURNOVER--
P/E (TTM)-18.9002
% RANGE4.53%
EPS(TTM)-0.7365
P/E(FORWARD)-33.9512
P/B3.121
BVPS4.460
DIVIDEND--
P/S103.57
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.70B
SHARES OUTSTANDING128.85M
NEXT EARNINGS--
FREE FLOAT122.32M
LOT SIZE1
EX-DATE01/10/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6h ago
Why Mesoblast's Move Into DMD Warrants A Speculative Buy (Upgrade)
Seeking Alpha·12h ago
Mesoblast gains as FDA clears study to test Ryoncil in Duchenne
TipRanks·14h ago
Mesoblast receives IND clearance from FDA for Ryoncil trial
Seeking Alpha·1d ago
Mesoblast drops after Ryoncil sales data for March quarter
Benzinga·1d ago
Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga·1d ago
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
TipRanks·1d ago
Mesoblast reports March quarter Ryoncil sales of $30.3M
Reuters·04/01 10:25
Mesoblast CEO Silviu Itescu files initial beneficial ownership statement
Same Industry
Name/Symbol
Change%
Price